1-Methylnicotinamide

From WikiMD's WELLNESSPEDIA

1-Methylnicotinamide.svg

Chemical compound

1-Methylnicotinamide (1-MNA) is a chemical compound that is a derivative of nicotinamide, a form of vitamin B3. It is also known as N-methylnicotinamide or trigonellinamide.

Chemical Structure and Properties[edit]

1-Methylnicotinamide has the IUPAC name N-Methylpyridine-3-carboxamide. Its molecular formula is C7H8N2O, and it has a molar mass of 136.15 g/mol. The compound is characterized by a pyridine ring with a carboxamide group at the 3-position and a methyl group attached to the nitrogen atom.

Biological Role[edit]

1-Methylnicotinamide is a metabolite of nicotinamide and is involved in various biological processes. It is known to exhibit anti-inflammatory and vasoprotective properties. The compound is also studied for its potential role in cardiovascular diseases and diabetes.

Metabolism[edit]

1-Methylnicotinamide is produced in the body through the methylation of nicotinamide by the enzyme nicotinamide N-methyltransferase (NNMT). This process is part of the NAD+ salvage pathway, which is crucial for maintaining cellular energy balance and redox reactions.

Medical Research[edit]

Research on 1-Methylnicotinamide has shown its potential therapeutic effects in various conditions. Studies suggest that it may help in reducing inflammation, improving endothelial function, and protecting against oxidative stress. These properties make it a subject of interest in the treatment of cardiovascular diseases, diabetes, and other inflammatory conditions.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.